Reaching Others University at Buffalo - The State University of New York
Skip to Content
Official UB news and information for the media

News Releases

All of the latest news about our university.


An oral biologic medication has successfully treated chronic, precancerous inflammation in the intestine, according to results of an animal study authored by an MD/PhD student in the University at Buffalo School of Medicine and Biomedical Sciences.


Gov. Andrew M. Cuomo has appointed Michael W. Cropp, MD, MBA, president and CEO of Independent Health, to the University at Buffalo Council. His term will run through June 2020.


The therapy, derived from a protein found in tarantula venom, shows promise for treating a fatal form of childhood muscular dystrophy.

event poster showing a black-and-white drawn brain

The beloved event series, launched in 2009, kicks off a new season in October.


Pop quiz: How has Praxair enriched the educational experience for University at Buffalo students?


As national leaders grapple with health care reform, an increasing number physicians and health care administrators are looking to strengthen their business skills to improve the patient experience and the value of care delivered in their organizations.


It is not only prenatal drug exposure, but also conditions related to drug use that can influence negative behavior in children, according to a new study from the University at Buffalo’s Research Institute on Addictions.


The $765 million class action settlement of concussion claims for retired NFL players that won preliminary approval in the U.S. Court of Appeals is a “potential template” for other professional athletes, says University at Buffalo Law School faculty member Christine P. Bartholomew, who is an expert on class action and antitrust litigation.


The Department of Epidemiology and Environmental Health in the University at Buffalo School of Public Health and Health Professions (SPHHP) has developed a new intradepartmental division in Health Services Policy and Practice.


The program targets infants and toddlers with, or at high risk for, developmental disabilities.